Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.

Cipriani A, Saunders K, Attenburrow MJ, Stefaniak J, Panchal P, Stockton S, Lane TA, Tunbridge EM, Geddes JR, Harrison PJ.

Mol Psychiatry. 2016 Oct;21(10):1324-32. doi: 10.1038/mp.2016.86. Epub 2016 May 31.

2.

Current and emerging therapies for the management of bipolar disorders.

El-Mallakh RS, Elmaadawi AZ, Gao Y, Lohano K, Roberts RJ.

J Cent Nerv Syst Dis. 2011 Aug 7;3:189-97. doi: 10.4137/JCNSD.S4441. Print 2011.

3.

Antipsychotic medication for early episode schizophrenia.

Bola J, Kao D, Soydan H.

Cochrane Database Syst Rev. 2011 Jun 15;(6):CD006374. doi: 10.1002/14651858.CD006374.pub2. Review.

4.

Efficacy of antimanic treatments: meta-analysis of randomized, controlled trials.

Yildiz A, Vieta E, Leucht S, Baldessarini RJ.

Neuropsychopharmacology. 2011 Jan;36(2):375-89. doi: 10.1038/npp.2010.192. Epub 2010 Oct 27. Review.

5.

Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis.

Tamayo JM, Zarate CA Jr, Vieta E, Vázquez G, Tohen M.

Int J Neuropsychopharmacol. 2010 Jul;13(6):813-32. doi: 10.1017/S1461145709991246. Epub 2010 Feb 4. Review.

6.

Comparison of mania patients suitable for treatment trials versus clinical treatment.

Talamo A, Baldessarini RJ, Centorrino F.

Hum Psychopharmacol. 2008 Aug;23(6):447-54. doi: 10.1002/hup.952.

7.

Neuropsychiatric consequences of cardiovascular medications.

Huffman JC, Stern TA.

Dialogues Clin Neurosci. 2007;9(1):29-45. Review.

Items per page

Supplemental Content

Write to the Help Desk